Publications

Review Article

Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer

Cancer Vaccines

2017

Authors:

Watt WC, Cecil DL, Disis ML.

Journal:

Seminars in Immunopathology

Volume:

39(3)

Page:

245-253

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/27975138/

Original Article

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo

Cancer Vaccines

2017

Authors:

Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.

Journal:

Clinical Cancer Research

Volume:

23(13)

Page:

3396-3404

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/28039264/

Original Article

Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer

Cancer Vaccines

2016

Authors:

Ebben JD, Lubet RA, Gad E, Disis ML, You M.

Journal:

Molecular Carcinogensis

Volume:

55(11)

Page:

1517-1525

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/26346412/

Review Article

The Human Vaccines Project: A roadmap for cancer vaccine development

Cancer Vaccines

2016

Authors:

Romero P, Banchereau J, Bhardwaj N, Cockett M, Disis ML, Dranoff G, Gilboa E, Hammond SA, Hershberg R, Korman AJ, Kvistborg P, Melief C, Mellman I, Palucka AK, Redchenko I, Robins H, Sallusto F, Schenkelberg T, Schoenberger S, Sosman J, Türeci Ö, Van den Eynde B, Koff W, Coukos G.

Journal:

Science Translational Medicine

Volume:

8(334)

Page:

8(334)

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/27075624/

Review Article

Current methods of epitope identification for cancer vaccine design

Cancer Vaccines

2015

Authors:

Cherryholmes GA, Stanton SE, Disis ML.

Journal:

Vaccine

Volume:

33(51)

Page:

7408-7414

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/26238725/

Review Article

The antigenic repertoire of premalignant and high-risk lesions

Cancer Vaccines

2015

Authors:

Marquez JP, Stanton SE, Disis ML.

Journal:

Cancer Prevention Research

Volume:

8(4)

Page:

266-70

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/25572327/

Original Article

Designing vaccines to prevent breast cancer recurrence or invasive disease

Cancer Vaccines

2015

Authors:

Stanton SE, Disis ML.

Journal:

Immunotherapy

Volume:

7(2)

Page:

69-72

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/25713984/

Original Article

Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity

Cancer Vaccines

2014

Authors:

Cecil, D.L., Holt, G.E., Park, K.H., Gad, E., Rastetter, L., Childs, J., Higgins, D., and Disis, M.L.

Journal:

Cancer Research

Volume:

74(10)

Page:

2710-8

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/24778415/

Original Article

Th1 epitope selection for clinically effective cancer vaccines

Cancer Vaccines

2014

Authors:

Disis ML, Watt WC, Cecil DL.

Journal:

Oncoimmunology

Volume:

3(9)

Page:

e954971

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/25941610/

Original Article

T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity

Cancer Vaccines

2013

Authors:

Cecil DL, Park KH, Gad E, Childs JS, Higgins DM, Plymate SR, Disis ML

Journal:

Breast Cancer Research and Treatment

Volume:

139(3)

Page:

657-65

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/23749321/